Skip to Content
Rank 3449
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 111 WEST LEMON AVE, MONROVIA, CA, US

Xencor - Key figures

Market cap 1.81 Billion
Revenue 326.64 Million
Profit 82.6 Million
P/E Ratio 16.03
P/s Ratio 5.55
Buy $XNCR at eToro

Xencor - Description

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed to treat cancer patients and autoimmune diseases in the United States and internationally.

The company is headquartered in Monrovia, California.